The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies
Authors:
Open Access
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (51) , 19616-19634
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Increased Cell Surface Free Thiols Identify Effector CD8+ T Cells Undergoing T Cell Receptor StimulationPLOS ONE, 2013
- Expression of Recombinant AntibodiesFrontiers in Immunology, 2013
- Label-Free Quantitation of Protein Modifications by Pseudo Selected Reaction Monitoring with Internal Reference PeptidesJournal of Proteome Research, 2012
- Interleukin-2 signalling is modulated by a labile disulfide bond in the CD132 chain of its receptorOpen Biology, 2012
- Rituximab resistanceBest Practice & Research Clinical Haematology, 2011
- Labile disulfide bonds are common at the leucocyte cell surfaceOpen Biology, 2011
- Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor OxygenationCancers, 2010
- Conformational changes in oxidatively stressed monoclonal antibodies studied by hydrogen exchange mass spectrometryProtein Science, 2010
- Skyline: an open source document editor for creating and analyzing targeted proteomics experimentsBioinformatics, 2010
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941Cancer Cell, 2009